|
ECHDC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.785230E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.208800E-01 |
| Normal-vs-Stage2 |
1.578190E-01 |
| Normal-vs-Stage3 |
6.982100E-02 |
| Normal-vs-Stage4 |
2.155100E-03 |
| Stage1-vs-Stage2 |
1.772360E-01 |
| Stage1-vs-Stage3 |
6.850100E-02 |
| Stage1-vs-Stage4 |
3.496900E-03 |
| Stage2-vs-Stage3 |
9.912400E-01 |
| Stage2-vs-Stage4 |
2.336800E-01 |
| Stage3-vs-Stage4 |
1.590380E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.602400E-02 |
| Normal-vs-AfricanAmerican |
7.884000E-01 |
| Normal-vs-Asian |
8.097000E-01 |
| Caucasian-vs-AfricanAmerican |
2.163400E-01 |
| Caucasian-vs-Asian |
1.316830E-01 |
| AfricanAmerican-vs-Asian |
9.035800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.207500E-02 |
| Normal-vs-Female |
3.209000E-01 |
| Male-vs-Female |
2.167200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.141800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.173980E-01 |
| Normal-vs-Age(61-80Yrs) |
2.930500E-02 |
| Normal-vs-Age(81-100Yrs) |
7.236800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.355830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.447600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.506600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.570600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.798400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.266600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.765200E-01 |
| Classical-VS-Follicular |
3.417200E-01 |
| Classical-VS-Other |
2.710000E-01 |
| Classical-VS-Normal |
6.230000E-01 |
| Tall-VS-Follicular |
7.893400E-01 |
| Tall-VS-Other |
6.092400E-01 |
| Tall-VS-Normal |
1.630050E-01 |
| Follicular-VS-Other |
6.008200E-01 |
| Follicular-VS-Normal |
2.312400E-01 |
| Other-VS-Normal |
1.445580E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.113800E-01 |
| Normal-vs-N1 |
5.230200E-02 |
| N0-vs-N1 |
2.382600E-01 |
|
|
